7.00
Schlusskurs vom Vortag:
$7.17
Offen:
$7.08
24-Stunden-Volumen:
29,695
Relative Volume:
0.40
Marktkapitalisierung:
$31.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.56M
KGV:
-0.4162
EPS:
-16.82
Netto-Cashflow:
$-12.46M
1W Leistung:
-3.05%
1M Leistung:
-6.67%
6M Leistung:
+21.42%
1J Leistung:
+56.60%
Tenax Therapeutics Inc Stock (TENX) Company Profile
Firmenname
Tenax Therapeutics Inc
Sektor
Branche
Telefon
919-855-2100
Adresse
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Vergleichen Sie TENX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TENX
Tenax Therapeutics Inc
|
7.00 | 32.71M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.13 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.18 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.25 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.11 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.73 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-24 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-14 | Eingeleitet | Guggenheim | Buy |
| 2024-09-30 | Eingeleitet | William Blair | Outperform |
| 2017-05-18 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Eingeleitet | MLV & Co | Buy |
| 2014-11-18 | Eingeleitet | WallachBeth | Buy |
Alle ansehen
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
Can trapped investors hope for a rebound in Tenax Therapeutics Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - newser.com
Forecasting Tenax Therapeutics Inc. price range with options dataWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
How sentiment analysis helps forecast Tenax Therapeutics Inc.Quarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com
Should you hold or exit Tenax Therapeutics Inc. now2025 Breakouts & Breakdowns & Consistent Profit Alerts - newser.com
Understanding Tenax Therapeutics Inc.’s price movementWeekly Trade Summary & Consistent Profit Focused Trading Strategies - newser.com
Why Tenax Therapeutics Inc. stock is a must watch in 2025Sell Signal & Community Consensus Trade Alerts - newser.com
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Investing News Network
Top chart patterns to watch in Tenax Therapeutics Inc.CEO Change & High Win Rate Trade Tips - newser.com
Why retail investors favor Tenax Therapeutics Inc. stockMarket Movement Recap & Smart Investment Allocation Tips - newser.com
How Tenax Therapeutics Inc. stock compares to growth peersEarnings Beat & High Accuracy Swing Trade Signals - newser.com
Combining machine learning predictions for Tenax Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com
Is now a turning point for Tenax Therapeutics Inc.Earnings Recap Report & Technical Confirmation Trade Alerts - newser.com
Historical volatility pattern of Tenax Therapeutics Inc. visualizedJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Will Tenax Therapeutics Inc. stock recover after recent dropTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
Will Tenax Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Analyzing drawdowns of Tenax Therapeutics Inc. with statistical toolsJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - newser.com
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):